These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 25548993)

  • 61. Multiple cutaneous lymphoproliferative disorders showing a retained tumor clone by T-cell receptor gene rearrangement analysis: a case series of four patients and review of the literature.
    Stowman AM; Hsia LL; Kanner WA; Mahadevan MS; Bullock GC; Patterson JW
    Int J Dermatol; 2016 Feb; 55(2):e62-71. PubMed ID: 26266670
    [TBL] [Abstract][Full Text] [Related]  

  • 62. T-cell receptor gene rearrangement analysis: cutaneous T cell lymphoma, peripheral T cell lymphoma, and premalignant and benign cutaneous lymphoproliferative disorders.
    Zelickson BD; Peters MS; Muller SA; Thibodeau SN; Lust JA; Quam LM; Pittelkow MR
    J Am Acad Dermatol; 1991 Nov; 25(5 Pt 1):787-96. PubMed ID: 1839392
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Mycosis fungoides and Sézary syndrome: diagnostic and prognostic relevance of cellular antigen expression].
    Meissner K; Löning T; Rehpenning W
    Hautarzt; 1991 Feb; 42(2):84-91. PubMed ID: 2037492
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Alemtuzumab treatment for Sézary syndrome: A single-center experience.
    Novelli S; García-Muret P; Sierra J; Briones J
    J Dermatolog Treat; 2016; 27(2):179-81. PubMed ID: 26329989
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Successful treatment of chemotherapy-refractory Sézary syndrome with alemtuzumab (Campath-1H).
    Gautschi O; Blumenthal N; Streit M; Solenthaler M; Hunziker T; Zenhäusern R
    Eur J Haematol; 2004 Jan; 72(1):61-3. PubMed ID: 14962265
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma.
    Poenitz N; Simon-Ackermann J; Gratchev A; Qadoumi M; Klemke CD; Stadler R; Kremer A; Radenhausen M; Henke U; Assaf C; Utikal J; Goerdt S; Dippel E
    Dermatology; 2005; 211(2):84-92. PubMed ID: 16088151
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Analysis of beta, gamma, and delta T-cell receptor genes in mycosis fungoides and Sezary syndrome.
    Whittaker SJ; Smith NP; Jones RR; Luzzatto L
    Cancer; 1991 Oct; 68(7):1572-82. PubMed ID: 1654197
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Bexarotene treatment of late-stage mycosis fungoides and Sézary syndrome: development of extracutaneous lymphoma in 6 patients.
    Bouwhuis SA; Davis MD; el-Azhary RA; McEvoy MT; Gibson LE; Knudsen JM; Kist JM; Pittelkow MR
    J Am Acad Dermatol; 2005 Jun; 52(6):991-6. PubMed ID: 15928617
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The MicroRNA Expression Profile Differs Between Erythrodermic Mycosis Fungoides and Sézary Syndrome.
    Rittig AH; Lindahl LM; Johansen C; Celis P; Ødum N; Iversen L; Litman T
    Acta Derm Venereol; 2019 Nov; 99(12):1148-1153. PubMed ID: 31453630
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [CD30 positive pilotropic lymphoma].
    Trémeau-Martinage C; Gorguet B; Lamant L; Brousset P; Loche F; Fillola G; Corberand J; Tkaczuck J; Bazex J
    Ann Dermatol Venereol; 1999 May; 126(5):434-8. PubMed ID: 10434108
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Naïve/memory T-cell phenotypes in leukemic cutaneous T-cell lymphoma: Putative cell of origin overlaps disease classification.
    Horna P; Moscinski LC; Sokol L; Shao H
    Cytometry B Clin Cytom; 2019 May; 96(3):234-241. PubMed ID: 30328260
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The molecular pathogenesis of mycosis fungoides and Sézary syndrome.
    Döbbeling U
    G Ital Dermatol Venereol; 2008 Dec; 143(6):385-94. PubMed ID: 19169211
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mogamulizumab in the treatment of advanced mycosis fungoides and Sézary syndrome: safety and efficacy.
    Lewis DJ; Rook AH
    Expert Rev Anticancer Ther; 2020 Jun; 20(6):447-452. PubMed ID: 32320304
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal.
    Agar NS; Wedgeworth E; Crichton S; Mitchell TJ; Cox M; Ferreira S; Robson A; Calonje E; Stefanato CM; Wain EM; Wilkins B; Fields PA; Dean A; Webb K; Scarisbrick J; Morris S; Whittaker SJ
    J Clin Oncol; 2010 Nov; 28(31):4730-9. PubMed ID: 20855822
    [TBL] [Abstract][Full Text] [Related]  

  • 75. CD30 As a Target for the Treatment of Cutaneous T-Cell Lymphoma.
    Prince HM
    J Clin Oncol; 2015 Nov; 33(32):3691-6. PubMed ID: 26392103
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Cells in the epidermotropic lymphomas (mycosis fungoides and Sézary syndrome. Study using monoclonal antibodies].
    Thivolet J; Schmitt D; Souteyrand P; Brochier J
    Nouv Presse Med; 1982 Oct; 11(41):3033-8. PubMed ID: 6755391
    [TBL] [Abstract][Full Text] [Related]  

  • 77. High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas.
    Valencak J; Schmid K; Trautinger F; Wallnöfer W; Muellauer L; Soleiman A; Knobler R; Haitel A; Pehamberger H; Raderer M
    J Dermatol Sci; 2011 Dec; 64(3):185-90. PubMed ID: 21937200
    [TBL] [Abstract][Full Text] [Related]  

  • 78. BCL2 and JUNB abnormalities in primary cutaneous lymphomas.
    Mao X; Orchard G; Lillington DM; Child FJ; Vonderheid EC; Nowell PC; Bagot M; Bensussan A; Russell-Jones R; Young BD; Whittaker SJ
    Br J Dermatol; 2004 Sep; 151(3):546-56. PubMed ID: 15377339
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Correlations between clinical and pathological features in 17 cases of mycosis fungoides before and after transformation.
    Bittencourt AL; Oliveira PD; Carvalho-Andrade A; Araújo I
    Int J Dermatol; 2015 Sep; 54(9):e327-31. PubMed ID: 26147565
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Detection of t(2;5)(p23;q35) translocation by reverse transcriptase polymerase chain reaction and in situ hybridization in CD30-positive primary cutaneous lymphoma and lymphomatoid papulosis.
    Beylot-Barry M; Lamant L; Vergier B; de Muret A; Fraitag S; Delord B; Dubus P; Vaillant L; Delaunay M; MacGrogan G; Beylot C; de Mascarel A; Delsol G; Merlio JP
    Am J Pathol; 1996 Aug; 149(2):483-92. PubMed ID: 8701987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.